These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29755309)

  • 1. Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles.
    Chen Z; Liu F; Chen Y; Liu J; Wang X; Chen AT; Deng G; Zhang H; Liu J; Hong Z; Zhou J
    Adv Funct Mater; 2017 Dec; 27(46):. PubMed ID: 29755309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome.
    Zhen S; Takahashi Y; Narita S; Yang YC; Li X
    Oncotarget; 2017 Feb; 8(6):9375-9387. PubMed ID: 28030843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs.
    Lin Y; Wu J; Gu W; Huang Y; Tong Z; Huang L; Tan J
    Adv Sci (Weinh); 2018 Apr; 5(4):1700611. PubMed ID: 29721412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core-Shell Nanocarrier.
    Wang P; Zhang L; Xie Y; Wang N; Tang R; Zheng W; Jiang X
    Adv Sci (Weinh); 2017 Nov; 4(11):1700175. PubMed ID: 29201613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9.
    He ZY; Zhang YG; Yang YH; Ma CC; Wang P; Du W; Li L; Xiang R; Song XR; Zhao X; Yao SH; Wei YQ
    Hum Gene Ther; 2018 Feb; 29(2):223-233. PubMed ID: 29338433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 8. A zwitterionic polymer-inspired material mediated efficient CRISPR-Cas9 gene editing.
    Zhang L; Yang L; Huang J; Chen S; Huang C; Lin Y; Shen A; Zheng Z; Zheng W; Tang S
    Asian J Pharm Sci; 2022 Aug; 17(5):666-678. PubMed ID: 36382298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering CRISPR: a review of the challenges and approaches.
    Lino CA; Harper JC; Carney JP; Timlin JA
    Drug Deliv; 2018 Nov; 25(1):1234-1257. PubMed ID: 29801422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9-Mediated Knockin of Retinoschisin 1 Gene-A Potential Nonviral Therapeutic Solution for X-Linked Juvenile Retinoschisis.
    Chou SJ; Yang P; Ban Q; Yang YP; Wang ML; Chien CS; Chen SJ; Sun N; Zhu Y; Liu H; Hui W; Lin TC; Wang F; Zhang RY; Nguyen VQ; Liu W; Chen M; Jonas SJ; Weiss PS; Tseng HR; Chiou SH
    Adv Sci (Weinh); 2020 May; 7(10):1903432. PubMed ID: 32440478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Genome Editing Using CRISPR/Cas9.
    Ding Y; Li H; Chen LL; Xie K
    Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes.
    Sousa DA; Gaspar R; Ferreira CJO; Baltazar F; Rodrigues LR; Silva BFB
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 - An evolving biological tool kit for cancer biology and oncology.
    Tian X; Gu T; Patel S; Bode AM; Lee MH; Dong Z
    NPJ Precis Oncol; 2019; 3():8. PubMed ID: 30911676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Methods of Delivering CRISPR/Cas9 Into Cells.
    Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
    Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.